Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push
The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers like India won't be easy.
Consumer News and Business Channel
This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.
Read at original outlet ↗